SmallCellSMASHERS
@SclcSMASHERS
Followers
293
Following
340
Media
6
Statuses
221
Advocacy group/voice of patients with #SCLC & loved ones. Mission: #community - awareness for #research - end #stigma - spread #hope @drshieldsmd @lungevity
Indianapolis, IN
Joined April 2024
As 2024 comes to a close, we would like to celebrate the advancements made in small cell lung cancer (#SCLC) that provide hope. This tremendous progress by clinical trials reflects the innumerable sacrifices made by such dedicated patients & their wonderful families. Thank you!
1
9
29
RT @drshieldsmd: Thank you @UpstageLungCanc for sharing the exciting progress that brings HOPE in #SCLC! . Listen to the podcast episode :….
0
4
0
RT @drshieldsmd: This is 40! Thank you to my sweet friends & family for ALL the amazing messages, gifts, and memories to make my day so spe….
0
1
0
RT @g_mountzios: 3 weeks after @ASCO25, let’s digest the data from the landmark DeLLphi-304 trial published in @NEJM that changed the >30….
0
23
0
RT @drshieldsmd: Thank you to Dr. Nasser Hanna (@hannawants2ELCN @IUCancerCenter) & Dr. Michael Gieske (@mrgieske @StElizabethNKY) for a wo….
0
4
0
RT @drshieldsmd: Honored to be invited to join the @IASLC Rare Tumors Committee! . Thankful for the opportunity to contribute to this amazi….
0
2
0
RT @drshieldsmd: Thank you to Live Lung @LiveLung1 for sharing my life story and my “why.” #LCSM @SclcSMASHERS.
0
4
0
RT @drshieldsmd: Thank you Live Lung @LiveLung1 for shedding light 💡 on such an important topic. The search for biomarkers in lung cancer,….
0
3
0
RT @drshieldsmd: Thank you to Live Lung @LiveLung1 to helping spread the word on how tissue biopsies can be sometimes limited due to crush….
0
3
0
RT @drshieldsmd: Thank you to Live Lung @LiveLung1 for highlighting the need to expand lung cancer screening criteria - to help capture ALL….
0
5
0
RT @drshieldsmd: True joy to be a guest on Upstage Lung Cancer @UpstageLungCanc podcast focused on HOPE ⭐️ in #SCLC!. Host @HildyGrossman,….
0
6
0
RT @lungoncdoc: Our @MDAndersonNews thoracic oncology rotation journal club for the fellows is about to be 🔥 🔥 #ASCO25 .
0
12
0
RT @LUNGevity: Join us for a Facebook Live on 6/20, w/ @mrgieske (@StElizabethNKY) & Nasser Hanna, MD (@IUMedSchool) where they will presen….
0
2
0
RT @drshieldsmd: Thankful to God, my family, amazing mentors @hannawants2ELCN @christine_lovly & pt advocate @jillfeldman4, our patients &….
0
5
0
RT @lungoncdoc: #DeLLphi304 results as presented by @charlesrudin here at #ASCO25 — how best to sequence our treatment options in ES-SCLC a….
0
6
0
RT @drshieldsmd: Dr. Xinghao Ai presents Phase 2 ZG006 10 vs 30 mg 3L+ ES-SCLC at #ASCO25 . ZG006 (Alvetamig) demonstrated high ORR (62.5%….
0
4
0
RT @LaurenByersMD: Striking activity with ABBV-706 SEZ6 ADC in high grade neuroendocrine cancer (NECs) where active therapies are urgently….
0
18
0
RT @Tony_Calles: 💡 After 2 oral presentations that definitively change the treatment landscape and impacts in survival for patients with ES….
0
29
0
RT @drshieldsmd: Dr. Charlie Rudin @charlesrudin @MSKCancerCenter presents long-awaited DeLLphi-304 tarlatamab vs chemotx in ES-SCLC at #AS….
0
10
0
RT @lungoncdoc: Take a BiTE out of this tarlatamab roadmap. More to come for our patients with small cell lung cancer! 🍎. #ASCO25 @ASCO @Sc….
0
12
0
